Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS)
CNY 8.28
(-0.12%)
CNY 8.28
(-0.12%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.36 Billion CNY | -30.53% |
| 2022 | 1.82 Billion CNY | 18.05% |
| 2021 | 1.54 Billion CNY | 31.22% |
| 2020 | 1.18 Billion CNY | 21.99% |
| 2019 | 967.84 Million CNY | -2.53% |
| 2018 | 992.98 Million CNY | 0.69% |
| 2017 | 986.16 Million CNY | 33.47% |
| 2016 | 738.89 Million CNY | 29.81% |
| 2015 | 569.21 Million CNY | 73.84% |
| 2014 | 327.43 Million CNY | 58.5% |
| 2013 | 206.57 Million CNY | 321.98% |
| 2012 | 48.95 Million CNY | -88.43% |
| 2011 | 423.12 Million CNY | 122.26% |
| 2010 | 190.36 Million CNY | 261.39% |
| 2009 | 52.67 Million CNY | -9.69% |
| 2008 | 58.33 Million CNY | -22.77% |
| 2007 | 75.52 Million CNY | 233.57% |
| 2006 | 22.64 Million CNY | 1.5% |
| 2005 | 22.3 Million CNY | 131.39% |
| 2004 | -71.05 Million CNY | -255.87% |
| 2003 | 45.58 Million CNY | -13.29% |
| 2002 | 52.57 Million CNY | 42.4% |
| 2001 | 36.92 Million CNY | -33.01% |
| 2000 | 55.11 Million CNY | -34.78% |
| 1999 | 84.49 Million CNY | -20.06% |
| 1998 | 105.7 Million CNY | 0.37% |
| 1997 | 105.31 Million CNY | -10.82% |
| 1996 | 118.09 Million CNY | 14.23% |
| 1995 | 103.38 Million CNY | 43.48% |
| 1994 | 72.05 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 181.04 Million CNY | 158.17% |
| 2024 Q1 | 214.45 Million CNY | -52.76% |
| 2024 Q2 | -311.25 Million CNY | -245.14% |
| 2023 Q3 | 316.5 Million CNY | 15.98% |
| 2023 Q2 | 272.89 Million CNY | -5.77% |
| 2023 Q4 | 453.92 Million CNY | 43.42% |
| 2023 FY | 1.27 Billion CNY | -30.53% |
| 2023 Q1 | 289.6 Million CNY | 55.97% |
| 2022 Q1 | 980.39 Million CNY | 238.66% |
| 2022 Q3 | 259.4 Million CNY | -35.7% |
| 2022 Q4 | 185.68 Million CNY | -28.42% |
| 2022 Q2 | 403.4 Million CNY | -58.85% |
| 2022 FY | 1.82 Billion CNY | 18.05% |
| 2021 Q1 | 404.17 Million CNY | 43.59% |
| 2021 Q2 | 391.86 Million CNY | -3.05% |
| 2021 Q3 | 463.73 Million CNY | 18.34% |
| 2021 Q4 | 289.49 Million CNY | -37.57% |
| 2021 FY | 1.54 Billion CNY | 31.22% |
| 2020 Q4 | 281.48 Million CNY | 10.24% |
| 2020 Q2 | 311.74 Million CNY | -6.13% |
| 2020 Q1 | 332.09 Million CNY | 111.75% |
| 2020 FY | 1.18 Billion CNY | 21.99% |
| 2020 Q3 | 255.34 Million CNY | -18.09% |
| 2019 Q4 | 156.83 Million CNY | -18.12% |
| 2019 FY | 967.84 Million CNY | -2.53% |
| 2019 Q3 | 191.54 Million CNY | -36.25% |
| 2019 Q1 | 319.03 Million CNY | 74.99% |
| 2019 Q2 | 300.43 Million CNY | -5.83% |
| 2018 Q3 | 177.26 Million CNY | -43.64% |
| 2018 FY | 992.98 Million CNY | 0.69% |
| 2018 Q4 | 182.31 Million CNY | 2.85% |
| 2018 Q1 | 318.86 Million CNY | 45.36% |
| 2018 Q2 | 314.54 Million CNY | -1.36% |
| 2017 Q4 | 219.35 Million CNY | -22.16% |
| 2017 Q2 | 240.01 Million CNY | -2.03% |
| 2017 FY | 986.16 Million CNY | 33.47% |
| 2017 Q1 | 244.99 Million CNY | 65.07% |
| 2017 Q3 | 281.79 Million CNY | 17.41% |
| 2016 Q3 | 221.36 Million CNY | 21.84% |
| 2016 Q1 | 187.41 Million CNY | 61.1% |
| 2016 FY | 738.89 Million CNY | 29.81% |
| 2016 Q4 | 148.42 Million CNY | -32.95% |
| 2016 Q2 | 181.69 Million CNY | -3.05% |
| 2015 FY | 569.21 Million CNY | 73.84% |
| 2015 Q4 | 116.33 Million CNY | -21.39% |
| 2015 Q3 | 147.98 Million CNY | -8.31% |
| 2015 Q2 | 161.39 Million CNY | 12.46% |
| 2015 Q1 | 143.5 Million CNY | 86.44% |
| 2014 Q4 | 76.97 Million CNY | -2.54% |
| 2014 FY | 327.43 Million CNY | 58.5% |
| 2014 Q1 | 92.89 Million CNY | 846.29% |
| 2014 Q2 | 78.58 Million CNY | -15.41% |
| 2014 Q3 | 78.97 Million CNY | 0.51% |
| 2013 Q2 | 57.57 Million CNY | -25.75% |
| 2013 Q3 | 83.9 Million CNY | 45.71% |
| 2013 FY | 206.57 Million CNY | 321.98% |
| 2013 Q4 | -12.44 Million CNY | -114.84% |
| 2013 Q1 | 77.54 Million CNY | 181.07% |
| 2012 Q2 | 29.12 Million CNY | -42.7% |
| 2012 Q3 | 64.65 Million CNY | 121.98% |
| 2012 Q4 | -95.64 Million CNY | -247.95% |
| 2012 FY | 48.95 Million CNY | -88.43% |
| 2012 Q1 | 50.82 Million CNY | 194.01% |
| 2011 Q4 | -54.06 Million CNY | -113.03% |
| 2011 Q1 | 40.33 Million CNY | -5.36% |
| 2011 Q2 | 21.99 Million CNY | -45.47% |
| 2011 Q3 | 414.86 Million CNY | 1786.29% |
| 2011 FY | 423.12 Million CNY | 122.26% |
| 2010 Q4 | 42.61 Million CNY | -16.09% |
| 2010 Q2 | 52.57 Million CNY | 18.44% |
| 2010 FY | 190.36 Million CNY | 261.39% |
| 2010 Q1 | 44.39 Million CNY | 30241.76% |
| 2010 Q3 | 50.78 Million CNY | -3.41% |
| 2009 Q4 | 146.3 Thousand CNY | -99.23% |
| 2009 Q2 | 3.08 Million CNY | -89.91% |
| 2009 Q1 | 30.55 Million CNY | 271.51% |
| 2009 FY | 52.67 Million CNY | -9.69% |
| 2009 Q3 | 18.89 Million CNY | 513.31% |
| 2008 FY | 58.33 Million CNY | -22.77% |
| 2008 Q4 | -17.81 Million CNY | -166.4% |
| 2008 Q3 | 26.82 Million CNY | -0.99% |
| 2008 Q1 | 22.22 Million CNY | 285.72% |
| 2008 Q2 | 27.09 Million CNY | 21.92% |
| 2007 Q2 | 50.42 Million CNY | 133.49% |
| 2007 Q3 | 15.46 Million CNY | -69.33% |
| 2007 FY | 75.52 Million CNY | 233.57% |
| 2007 Q4 | -11.96 Million CNY | -177.36% |
| 2007 Q1 | 21.59 Million CNY | 143.99% |
| 2006 Q4 | -49.09 Million CNY | -291.22% |
| 2006 Q1 | 9.12 Million CNY | 1124.79% |
| 2006 Q3 | 25.67 Million CNY | -30.49% |
| 2006 FY | 22.64 Million CNY | 1.5% |
| 2006 Q2 | 36.93 Million CNY | 304.82% |
| 2005 Q2 | 13.71 Million CNY | 125.13% |
| 2005 Q1 | 6.09 Million CNY | 106.45% |
| 2005 Q3 | 3.39 Million CNY | -75.23% |
| 2005 Q4 | -890.35 Thousand CNY | -126.22% |
| 2005 FY | 22.3 Million CNY | 131.39% |
| 2004 Q2 | 10 Million CNY | -10.38% |
| 2004 FY | -71.05 Million CNY | -255.87% |
| 2004 Q4 | -94.45 Million CNY | -4332.86% |
| 2004 Q3 | 2.23 Million CNY | -77.69% |
| 2004 Q1 | 11.16 Million CNY | 128.22% |
| 2003 Q2 | 18.03 Million CNY | 79.94% |
| 2003 Q3 | 12.64 Million CNY | -29.86% |
| 2003 Q4 | 4.89 Million CNY | -61.33% |
| 2003 FY | 45.58 Million CNY | -13.29% |
| 2003 Q1 | 10.02 Million CNY | -32.41% |
| 2002 Q4 | 14.82 Million CNY | -1.18% |
| 2002 Q3 | 15 Million CNY | -61.84% |
| 2002 Q1 | -15.98 Million CNY | 0.0% |
| 2002 FY | 52.57 Million CNY | 42.4% |
| 2002 Q2 | 39.31 Million CNY | 346.03% |
| 2001 FY | 36.92 Million CNY | -33.01% |
| 2000 FY | 55.11 Million CNY | -34.78% |
| 1999 FY | 84.49 Million CNY | -20.06% |
| 1998 FY | 105.7 Million CNY | 0.37% |
| 1997 FY | 105.31 Million CNY | -10.82% |
| 1996 FY | 118.09 Million CNY | 14.23% |
| 1995 FY | 103.38 Million CNY | 43.48% |
| 1994 FY | 72.05 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 4.9 Billion CNY | 72.197% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 3.39 Billion CNY | 59.776% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 788.26 Million CNY | -73.175% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 82.83 Million CNY | -1547.871% |
| Aurora Optoelectronics Co.,Ltd. | -505.31 Million CNY | 370.147% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | -37.56 Million CNY | 3733.494% |
| NanJing Pharmaceutical Company Limited | 1.49 Billion CNY | 8.517% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 114.81 Million CNY | -1088.966% |